Relay Therapeutics Inc (RLAY) Company Profile & Statistics

Relay Therapeutics Inc
RLAY
(Nasdaq - US)
N/A
6.13
-0.22 (-3.46%)
in:usd•As of: Apr 25, 2024 13:12 UTC -4
Open
6.07
High
6.20
Low
5.83

About Relay Therapeutics Inc

CEO

Sanjiv K. Patel

Headquarters

399 binney street, 2nd floor

cambridge, ma 02139, united states

Auditor

Ernst & Young LLP

Employees

323

Share Holders

Website

www.relaytx.com

Industry

biotechnology

Sector

health technology

Company Overview

Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.

Relay Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	804.13M
Enterprise Value	660.40M
Enterprise Value/EBITDA (ttm)	-1.74
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.00
Price to Sales (ttm)	30.00
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	75.00%
Operating Margin (ttm)	-1263.49%
Profit Margin (ttm)	-31184.20%
Return on Equity (ttm)	-42.43%
Return on Invested Capital (ttm)	-42.38%
Return on Assets (ttm)	-36.47%

Income Statement

Revenue (ttm)	25.55M
Revenue Per Share (ttm)	0.19
Gross Profit (ttm)	25.55M
EBITDA (ttm)³	-378.49M
Net Income Avi to Common (ttm)	-341.97M
Diluted EPS (ttm)	-2.80

Share Statistics

Beta (5Y Monthly)	1.63
52-Week Change	-47.96%
S&P500 52-Week Change	23.65%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	131.18M
Dividend Yield	0.00%
Float ⁴	126.53M
% Held by Insiders	3.54%
% Held by Institutions	96.98%

Balance Sheet

Total Cash (mrq)	750.09M
Total Cash Per Share (mrq)	5.72
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	25.44%
Quick Ratio (mrq)	25.44%
Book Value Per Share (mrq)	5.90

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.45
Free Cash Flow (ytd)	-304.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Relay Therapeutics Inc

Trade With A Regulated Broker